🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Lewy Body Dementia Psychosis

Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis NCT07029581Phase 261 sites📍 Irvine📍 Aurora📍 Washington D.C. ACADIA Pharmaceuticals Inc. · Tests: ACP-204, Placebo Comparing Antipsychotic Medications in LBD Over Time NCT05590637Phase 42 sites📍 San Antonio📍 San Antonio The University of Texas Health Science Center at San Antonio · Tests: Pimavanserin, Quetiapine Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders NCT07509125NA1 site📍 Leuven Universitaire Ziekenhuizen KU Leuven · Tests: UHR PET/CT scan of the brain with ¹⁸F-FDG, UHR PET/CT scan of the brain with ¹⁸F-PE2I, UHR PET/CT scan of the brain wit… Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis NCT07095465Phase 332 sites📍 Irvine📍 Aventura📍 Boca Raton ACADIA Pharmaceuticals Inc. · Tests: ACP-204
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy